Disease | breast cancer |
Symptom | C0684830|axillary metastasis |
Sentences | 8 |
PubMedID- 24307349 | Systemic treatment of primary invasive breast cancer patients with synchronous axillary metastasis is currently based on the biomarker characteristics of the primary tumor; however, hormone receptors and her2 status may change throughout tumor progression from the primary tumor to the synchronous axillary metastasis. |
PubMedID- 23830035 | Conclusion: the detectability of small invasive breast cancers among patients with and without axillary metastasis is different with mammography, but not with us and mri. |
PubMedID- 23299541 | After reviewing the medical records, the following patients were excluded: male breast cancer (n=12), patients with axillary metastasis without an identifiable primary breast tumour (n=13), metastatic disease at diagnosis (n=13), patients who received preoperative radiation therapy alone (n=10) or underwent partial excisional biopsy before neoadjuvant chemotherapy (n=214). |
PubMedID- 22295236 | Studies on the feasibility and accuracy of sln biopsy after preoperative chemotherapy in locally advanced breast cancer patients with documented axillary metastasis are few and the results are inconclusive. |
PubMedID- 23779101 | In a series of breast cancer patients with axillary metastasis, corresponding surgically resected tumor and metastatic lymph node specimens have been tested for ck19 protein by ihc and for ck19 mrna by real-time pcr; furthermore, ck19 immunostaining has been performed in ncbs when available. |
PubMedID- 23091551 | It has been suggested that occult breast cancer with axillary metastasis should be treated in the same way as breast cancer with a comparable nodal stage is treated 6. |
PubMedID- 21614924 | We describe a case of breast cancer with lymph node axillary metastasis treated by ct-guided cryoablation. |
PubMedID- 19822403 | Breast mri in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. |
Page: 1